Skip to main content
OpenTrials

Clinical trial condition

Membranous Nephropathy

Explore clinical trials studying Membranous Nephropathy. Study availability and eligibility vary by location and protocol.

37 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Membranous Nephropathy trial results

Active, not recruiting

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

NCT05732402

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
Locations
  • Investigational Site (523) Phoenix, Arizona, United States
  • Investigational Site (501) Phoenix, Arizona, United States
  • Investigational Site (524) Tucson, Arizona, United States
  • Investigational Site (506) Valencia, California, United States
View all 30 locations
View Trial Details
Completed

Obinutuzumab in Primary MN

NCT05050214

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • ASST HPG23 - Unità di Nefrologia Bergamo, BG, Italy
  • Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò" Ranica, BG, Italy
View Trial Details
Completed

MOR202 for Refractory MN

NCT04893096

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • ASST HPG23 - Unità di Nefrologia Bergamo, BG, Italy
  • Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò" Ranica, BG, Italy
View Trial Details
Completed

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619

Conditions
Autoimmune Diseases, C3 Glomerulonephritis, Connective Tissue Diseases, +18 more
Locations
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • HealthONE Physician Care, Rocky Mountain Hospital for Children Denver, Colorado, United States
  • Washington Nephrology Associates Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

NCT04733040

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Managadze National Center of Urology Tbilisi, Georgia
  • Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic Tbilisi, Georgia
  • University Hospital Aachen Aachen, Germany
  • Charite Berlin, Germany
View all 25 locations
View Trial Details

Related conditions